Susan is a co-founder of QCTR. Susan has worked in the pharmaceutical industry since 1996 initially with Scotia Pharmaceuticals Ltd, a medium-sized pharma company and then with a virtual biotech company, Laxdale Ltd, that specialized in developing treatments for psychiatric and neurological disorders. Susan is responsible for setting the overall direction of the company, client relationship management, legal and contractual issues and overseeing regulatory services.

Susan is a member of the Institute of Chartered Accountants of Scotland and qualified with Ernst & Young. She has an honours degree in Accountancy from Stirling University.

Susan is a member of the Drug Information Association, the Royal Society of Medicine and the Entrepreneurial Exchange.

Fiona is a co-founder of QCTR. Fiona has worked in the Pharmaceutical Industry since 1989, initially with Boehringer Mannheim, then AstraZeneca, followed by Scotia Pharmaceuticals, a medium-sized pharma company. Fiona then moved to a virtual biotech company, Laxdale Ltd, specializing in developing treatments for psychiatric and neurological disorders. Fiona is responsible for the overall direction of clinical operations at QCTR including staff recruitment and training within the clinical team, and overseeing the delivery of contracted services as contained in the contract.

Fiona graduated with an honours degree in Biochemistry and Immunology from Strathclyde University and has a Post-Graduate Diploma in Information Technology Systems. Fiona is a Chartered Scientist, awarded by the UK Science Council and a professional member of the Institute of Clinical Research.

Crispin has been with QCTR since its inception and has worked in the pharmaceutical industry since 1995, initially at Scotia Pharmaceuticals Ltd, a medium sized pharmaceutical company and then at Laxdale Ltd, that specialized in developing treatments for psychiatric and neurological disorders. Crispin is responsible for regulatory affairs, including clinical trial authorisation applications and for medical writing.

Crispin has an honours degree in Animal Sciences from Reading University and a PhD in Dairy Science from Glasgow University. He is a member of the European Medical Writers Association and the Royal Society of Medicine.

Mark has been with QCTR in the role of Senior Clinical Project Manager since May 2008. He has worked in the pharmaceutical industry since 1985, initially at AstraZeneca, and then Johnson & Johnson Medical Ltd, followed by PPD, a large CRO. Mark is responsible for managing QCTR clinical trials, the overall study and team including study timelines, budgets and vendors.

Mark has a B.Sc. (Biology Major) from Stirling University.

Eric has been with QCTR in the role of Clinical Quality Assurance Manager since January 2010. He originally worked in the veterinary industry then moved to the pharmaceutical industry in 2003 gaining QC/QA experience with Bayer, Quintiles, LCG BioScience and Cognitive Drug Research. Eric is responsible for maintaining and reviewing QCTR’s Quality Management System and working procedures to ensure compliance with current, relevant regulations and guidelines.

Eric has diplomas in Veterinary Technology, Business Management and Marketing Management from colleges in South Africa, in conjunction with a BSc in Life Sciences through the Open University. Eric is a member of the British Association of Research Quality Assurance.

Amanda has been with QCTR since its inception as Company Secretary and has worked at a senior level within the pharmaceutical and CRO industry since 1996, initially with Scotia Pharmaceuticals Ltd, a medium-sized pharma company and a virtual biotech company, Laxdale Ltd, that specialized in developing treatments for psychiatric and neurological disorders. Amanda is responsible for all administrative, general finance and HR matters within the company.

Amanda is an Associate of the Institute of Chartered Secretaries and Administrators and has a BA from Stirling University and an MSc in Administrative and Information Management from Napier University.

Audrey has been with QCTR in the role of Business Development Manager since October 2009. She has worked in the pharmaceutical industry since 1991, initially with Pfizer, then Pharmaserve and Syntex, followed by 14 years at AstraZeneca. Audrey is responsible for identifying and following up new business opportunities, preparation of proposals and handling of customer service related issues.

Audrey has a BSc in Physiology, an MSc in Clinical Pharmacology and a PhD in sleep research.

Neil joined QCTR in December 2009 as Financial Controller. Neil previously worked as Finance Director to Haptogen prior to its acquisition by Wyeth Pharmaceuticals and as a Corporate Finance Advisor for Scottish Enterprise in the biotechnology sector. Neil is responsible for managing the financial affairs of the company.

Neil is ACCA qualified and has an HND in Accountancy from Bell College of Technology.